1942 · 34 citations · 0 references
MedicineEndocrinologyOncologyBreast OncologyCarcinogenesisTumor ProgressionHormonal TherapyHormone-related CarcinogenesisMammary Gland AnatomyMammary Gland DevelopmentMammary Tissue RemodelingMammary TumorsMammary Gland HistologyMammary Gland Hormonal RegulationMammary Gland MorphogenesisMammary GlandsMammary Stroma
The primary effect of estrogen on the mammary gland is to accelerate the development of the duct tree and its supporting fibrous tissue. This is accomplished by ripening or enlargement in the mammary epithelium as well as in cells of the stroma and addition of new elements through multiplication of cells. Susceptibility to cancer seem s to increase with physiologic age of the breast. Increasing the amount or duration of the stimulus beyond physiologic limits accelerates maturity and aging. Intense interrupted stimulation is not as effective as continuous estrogenic action obtained by implantation of pellets or by the use of estrogens with prolonged action. The total amount of estrogen needed to produce cancer is the same regardless of the daily dose injected. The time required is usually proportionate to the dose with a daily dose up to 200 mcg after which it increases. However mammary cancer occurs with smaller amounts of estrogen when pellets of the agents are implanted. Not all of the animals show the same rate of development of cancer and in some cases cancer cancer does not develop. The fibrosis occurring in the mammary gland serves as an index of the duration and intensity of estrogenic stimulation. No spontaneous mammary cancers had occurred in the authors colony of 5000 animals over a 7-year period. However mammary cancers were found in 202 of 555 rats that were treated with estrogens. The effect of a previous intense or prolonged period of estrogenic stimulation was found to persist as a latent cancerogenic influence in the breast. Ths suggested that human m ammary cancer may result from abnormally intense stimulation furing the adolescent period or during a previous pregnancy or from ovarian dysfunction resulting in hyperestrogenism over a period of years. Then superimposed intense or continuous estrogenic stimulation at the time of the menopause may cause cancer to develop. It has been the time of the menopause may cause cancer to develop. It has bee n shown that the incidence of human mammary cancer increases steadily with the age of population. Atrophy and degenerative changes may be etiologic factors. In the experiments on rats the time for the appearance of cancer was inversely proportional to the age of the rats when estrone pellets were implanted but with other methods no difference between young and old was found. Injections of either progesterone or testosterone alone caused increased lobular development but no cancers in mammary glands. When combined with estrone injections or pellets cancers developed. Pathologic changes were found in the pituitary thymus testes ovaries adrenals prostate vagina and uterine cervix of animals used in these experiments. Hypophysectomy prevented the effects of estrogens on the mammary gland so that no cancers developed. Another experiment showed that the growth of estrogenic-produced mammary cancer was partially inhibited by injections of anterior pituitary extracts.